248.616.021 Boehringer Ingelheim Investigational Site — Albany, New York

248.616.021 Boehringer Ingelheim Investigational Site is a clinical research site located in Albany, New York, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

248.616.021 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Restless Legs Syndrome.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 248.616.021 Boehringer Ingelheim Investigational Site?

248.616.021 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 248.616.021 Boehringer Ingelheim Investigational Site conducted?

248.616.021 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Restless Legs Syndrome.

Is 248.616.021 Boehringer Ingelheim Investigational Site accredited by Crixeo Health?

248.616.021 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 248.616.021 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.